REGN
40
-5
AES
40
3
LH
50
-2
AAP
45
-2
VRSK
35
-7
SLB
42
-6
SNA
53
-6
TXT
75
-3
KHC
45
-2
NDAQ
64
-5
VMC
60
-8
DVA
52
-5
DD
57
-3
FSLR
49
9
PEP
47
-3
MAC
41
-5
RRC
43
-7
XEL
44
-4
OXY
37
-8
ED
40
-5
REGN
40
-5
AES
40
3
LH
50
-2
AAP
45
-2
VRSK
35
-7
SLB
42
-6
SNA
53
-6
TXT
75
-3
KHC
45
-2
NDAQ
64
-5
VMC
60
-8
DVA
52
-5
DD
57
-3
FSLR
49
9
PEP
47
-3
MAC
41
-5
RRC
43
-7
XEL
44
-4
OXY
37
-8
ED
40
-5
Financhill
Back

RAPT Therapeutics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40

RAPT
RAPT Therapeutics

Last Price:
$10.64
Seasonality Move:
-6.61%

7 Day Trial

ALL ACCESS PASS

$ 7

RAPT Therapeutics Stock Forecast

  • Over the next 52 weeks, RAPT Therapeutics has on average historically fallen by 33.7% based on the past 5 years of stock performance.
  • RAPT Therapeutics has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
  • Is RAPT Therapeutics Stock Undervalued?
    The current RAPT Therapeutics [RAPT] share price is $10.61. The Score for RAPT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • RAPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will RAPT Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, RAPT Therapeutics has on average historically fallen by 33.7% based on the past 5 years of stock performance.

RAPT Therapeutics Stock Rating

Sell
40
RAPT Therapeutics (RAPT) is a Sell

Is RAPT Therapeutics overpriced?

  • RAPT Therapeutics has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%

RAPT Therapeutics Stock Price History

Is RAPT stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RAPT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
rapt.com

52-Week Data

52-Week High:
30.60
52-Week Low:
5.67

Prediction Charts

Market Cap:
175.4M
Price in USD:
10.61
Volume:
755K
Beta:
0.14

Technical Analysis

SMA50:
7.89
SMA100:
8.28
SMA200:
10.10
52-Wk Change:
-62.85%

Stock Predictions

  • Is RAPT Therapeutics stock public?
    Yes, RAPT Therapeutics is a publicly traded company.
  • What is the RAPT Therapeutics stock quote today?
    The RAPT Therapeutics stock price is 10.61 USD today.
  • How to buy RAPT Therapeutics stock online?
    You can buy RAPT Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-25 8.24 9.56 9.59 8.00
Jun-26 9.59 9.73 9.76 8.83
Jun-27 9.74 8.43 9.84 8.24
Jun-30 8.46 8.00 8.46 7.97
Jul-1 7.94 7.33 8.06 7.33
Jul-2 7.33 8.01 8.10 7.32
Jul-3 8.06 8.05 8.18 7.90
Jul-7 8.00 8.16 8.43 7.89
Jul-8 8.16 8.03 8.34 7.94
Jul-9 8.05 8.44 8.71 8.05
Jul-10 8.48 8.62 8.86 8.22
Jul-11 8.57 8.46 8.62 8.32
Jul-14 8.44 8.72 8.76 8.35
Jul-15 9.04 10.61 11.94 9.04

RAPT Therapeutics Earnings

RAPT Therapeutics Earnings Report: Per Share RAPT Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

RAPT Therapeutics Forecast Revenue Growth

RAPT Therapeutics Stock Analysis: Historical quarterly revenues per share for RAPT Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $3.99 per share, a decrease next quarter of $0.10 per share, an increase this year of $12.83 per share, and a decrease next year of $0.50 per share.

* RAPT Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.